Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240979 · ClinicalTrials.gov registry record
Establishing a Non-invasive Method to Measure Your Heart's Performance
A clinical trial of Heart Failure, sponsored by Marie Csete MD, PhD.
- Completed
- Registry status
- 72
- Enrollment target
- 2
- Study locations
NCT02240979: Completed study of Heart Failure, sponsored by Marie Csete MD, PhD.
NCT02240979 is a study of Heart Failure that has completed, run by Marie Csete MD, PhD. The registered enrollment target is 72 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02240979, a study of Heart Failure, has completed, sponsored by Marie Csete MD, PhD.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to evaluate a new way to examine cardiac function, using software developed at Caltech. The experimental device is software loaded on an iPhone. The iPhone is used to capture a pulse (waveform) by simply placing the iPhone lightly over the neck where the carotid pulse can be felt. In this study the information collected from the iPhone app is compared to cardiac function data obtained from the current gold standard for measuring cardiac function, cardiac magnetic resonance imaging (MRI). Subjects referred from cardiologists will also generally have echocardiography information available for comparison with the iPhone app. For the study, subjects will have completely non-invasive studies done in one setting: The iPhone app to capture the waveforms (over carotid and radial (wrist) arteries), tonometry (another non-invasive method using a modified stethoscope), standard pulse oximetry, followed by a 30 minute MRI examination of the heart. A second complete study will be done about 6 months after the first. The complete study session takes about 1.5 hours.
Conditions Studied
Interventions
- DEVICE cardiac MRI
Study Locations (2)
California
- Avicena LLC - Pasadena
- Huntington Medical Research Institutes MR Imaging Center - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2014-08 |
| Est. Completion | 2019-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02240979
The ClinicalTrials.gov registry entry for NCT02240979 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The listed sponsor is Marie Csete MD, PhD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which cardiac MRI is the first listed.
NCT02240979 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02240979 about?
NCT02240979 is a clinical study titled "Establishing a Non-invasive Method to Measure Your Heart's Performance". The purpose of the study is to evaluate a new way to examine cardiac function, using software developed at Caltech. The experimental device is software loaded on an iPhone. The iPhone is used to capture a pulse (waveform) by simply placing the iPhone lightly over the neck where the carotid pulse can...
What is the current status of trial NCT02240979?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2014-08. Estimated completion is 2019-05.
What conditions does trial NCT02240979 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02240979?
The interventions under investigation include: cardiac MRI (DEVICE).
Who is sponsoring clinical trial NCT02240979?
This trial is sponsored by Marie Csete MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02240979 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.